Objectives: To determine the correlation between various vancomycin MIC testing methodologies and explore the phenomenon of MIC creep.
Introduction
An MIC is a measure of antibiotic activity against bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). The value obtained is interpreted against established breakpoints to assist with antibiotic treatment decisions. In the treatment of MRSA bacteraemia, vancomycin MIC is important, as higher mortality has been associated with susceptible but high MICs (.1.5 mg/L by Etest). 1 The gold standard for measuring MIC remains broth microdilution (BMD). As this test is labour intensive, laboratories generally rely on automated systems for susceptibility profiles. However, the correlation between methods remains poorly studied with most data analysing agreement based on an assumed measurement error of +1 dilution. 2 The role of vancomycin is to be questioned both in the treatment of an individual patient and in its use as empirical therapy as a consequence of documented shifts in vancomycin MIC against MRSA over time or MIC creep. However, this phenomenon is controversial, as it has largely been limited to single-centre studies. 3 In the absence of MRSA typing, clonal dissemination cannot be excluded for some of these findings. We therefore undertook this study to determine the correlation between the commonly performed MIC methods (against the gold standard BMD) and the concept of MIC creep in a fully characterized isolate collection.
Methods
All MRSA bloodstream infection (BSI) isolates from the initial positive blood culture from Liverpool Hospital (Sydney, Australia) were included in the study. Isolates from 1997 to 2008 were retrieved from storage (2808C) and sub-cultured twice for 48 h on horse blood agar (HBA) prior to testing. All testing occurred over a 6 month period with no evidence of creep in MIC for the appropriate control strain (ATCC 29213) throughout the period. Results were read by two independent scientists, with discordant results between scientists resolved by a third scientist. To assess reproducibility, given the assumed error of testing (+1 dilution), a proportion of discordant results were repeated. Data analysis for MIC creep was limited to ST239-like isolates only (however, similar associations with nmrMRSA were detected). c Linear regression analysis was performed for geometric mean analysis while modal and isolate frequency analysis were performed after splitting the data into two time periods (1997-2003 and 2004-08) . P values are given (NS¼not significant; P.0.05). (Table 1) . Associations did not change if nmrMRSA clones were included in an overall analysis (data not shown). The presence of MIC creep was dependent on the method and variable used for analysis. Geometric mean MIC increased significantly over time by Etest only (P,0.01). In contrast, there was evidence of significant MIC decrease over time when using frequency analysis by BMD only, with the proportion of isolates with an MIC ≥2 mg/L declining from 19% in time period 1 to 6% in time period 2 (P,0.01). However, irrespective of method, the modal MIC was stable over time at 1 mg/L.
Discussion
This study confirms the previously reported moderate correlation between the gold standard BMD and alternative MIC methodologies (Vitek2 w and Etest). 8 Etest results were consistently higher than BMD at low MICs (≤1 mg/L). Similar to a recent study, Etest results were either concordant or 1 dilution lower than the gold standard at MIC¼ 2 mg/L. 8 Vitek2 w was consistently 1 -2 dilutions lower than BMD. Thus automated susceptibility testing would consistently underreport high MIC isolates. This is of concern given the association between MIC and outcome 1 and would suggest non-automated MIC testing for all invasive MRSA isolates. However, the current treatment guidelines recommend treatment decisions be based on clinical van Hal et al.
responses, not on MIC values. 9 Therefore these MIC differences detected in our study may not be clinically significant. However, if treatment is to be directed by MIC values, then testing with Etest is the methodology of choice. 10 This has significant laboratory implications, with non-automated MIC testing probably only feasible on a subset of MRSA isolates.
MIC creep was detected over the 12 years for Etest, but not for Vitek2 w and BMD based on geometric mean measurements only. The strengths of our study were that all isolates were typed and MIC creep analysis was limited to the predominant clone, thus eliminating the influence of clonal dissemination as a possible explanation. In addition, as testing was performed over 6 months, we were able to exclude batch-to-batch variation as a contributing factor in our results. Of note, MIC decrease was detected when analysing the proportion of isolates with an MIC ≥2 mg/Lwith BMD only. However, from the data it is clear that the selection and duration of the study period has a profound effect on these variables; for example, if the study interval ended in 2002, creep would have been detected by all variables (data not shown). Therefore, our data confirm previous suggestions that the best measure of central tendency is the modal MIC, 11 which remained stable over the entire time period, irrespective of method.
Possible explanations for the large variation in the high-MIC isolates remain unclear, and warrant further study. However, our data suggest that evolution of high-MIC isolates requires a high MRSA burden in at-risk patients in the appropriate hospital niche. This would explain the high-MIC 'outbreak' detected in 2001-02. Changes to subsequent rates may reflect changes in vancomycin dosing and target trough levels over time, although no changes in dosing policies were introduced over the 12 years.
A potential limitation of our study is that intra-observer variability was not corrected for over the 6 month testing period. However, this variable was reduced by undertaking two independent readings of the MIC, with discordant results resolved by a third person blinded to the other results. Similarly there was a high level of concordance when reproducibility was assessed.
In summary, vancomycin MIC creep is dependent on the method and measurement used for analysis and could not be detected when using the modal MIC. Correlations between testing methodologies remain moderate, therefore, in laboratories that use automated platforms, formal BMD MIC testing should be considered in the appropriate subset of patients.
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